Ian Degeling Email

Co-Founder . SeraNovo

Current Roles

Employees:
16
Revenue:
$3.2M
About
SeraNovo is a privately held Dutch pharmaceutical company with a proprietary technology platform to enhance the bioavailability of water insoluble drugs. SeraNovo's technology harnesses the unique benefits of deep eutectic solvents to create powerful, tailor-made solubility-enhancing formulations that are well tolerated and simple to produce. Since its incorporation in 2017, the company has secured multiple license deals, validating the potential of its technology. SeraNovo has a broad portfolio of programs progressing through clinical phases in 2021 and an established suit of intellectual property.
SeraNovo Address
Robert Boyleweg 4
Leiden, null
SeraNovo Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.